Therapeutics for the treatment of glaucoma
AssigneesMayo Foundation for Medical Education and Research, Regents of the University of Minnesota
InventorsMichael P. Fautsch, Peter Dosa, Michael A. Walters, Gunda I. Georg
Life of this patent
Estimating the term…
Abstract
The present invention provides benzothiadiazine and chroman derivatives and particularly diazoxide and cromakalim derivatives for use in treating glaucoma, retinopathy, treating age related macular degeneration, treating, stabilizing and/or inhibiting blood and lymph vascularization, and reducing intraocular pressure by administering a pharmaceutically effective amount of a prodrug disposed in an ophthalmically acceptable carrier to the eye, wherein the prodrug specifically modulates a KATP channel to reduce an intraocular pressure.
Claims20
A method to treat increased intraocular pressure, glaucoma, ocular hypertension, retinopathy, or age-related macular degeneration in a host in need thereof comprising administering an effective amount of a pharmaceutical formulation comprising a compound of the formula:
- or a pharmaceutically acceptable salt thereof;
- and one or more pharmaceutically acceptable excipients, wherein the pharmaceutical formulation can be administered topically in the eye, and wherein the formulation has a pH of 5.5-8 and an osmolality of 150-450 mOsm.
Dependencies are inferred from the claim text.